Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Rebody Health vs Vytora Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Rebody Health logo

Rebody Health

7.6
★★★3.8/5

Best for: Shoppers who want transparent, dose-based GLP-1 pricing with oral, injectable, or brand-name options

Visit Rebody Health
VS
Vytora Health logo

Vytora Health

8.4
★★★★4.2/5

Best for: compounded or brand-name GLP-1 with named pharmacy partners, 50 states

Visit Vytora Health

Rebody Health and Vytora Health are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Vytora Health starts lower at $150/mo versus $199.99/mo, and Vytora Health edges ahead overall (8.4 vs 7.6 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

Rebody Health

StartingCompounded
$199.99/mo
semaglutide

Weekly compounded injection from $199.99/mo, dose-scaled higher as the prescription increases; daily oral 'melt' semaglutide from $143.99/mo. $50 off first month.

StartingCompounded
$249.99/mo
tirzepatide

Weekly compounded injection from $249.99/mo, dose-scaled higher as the prescription increases; daily oral 'melt' tirzepatide from $249.99/mo.

BrandBrand-name
$420.99/mo
semaglutide

Brand Wegovy weekly pen from $420.99/mo; Wegovy oral tablets from $343.99/mo.

BrandBrand-name
$573.99/mo
tirzepatide

Brand Zepbound KwikPen from $573.99/mo.

Vytora Health

All dosesCompounded
$180/mo
semaglutide
3-mo bundle ($450 billed)Compounded
$150/mo
semaglutide
All dosesCompounded
$249/mo
tirzepatide
3-mo bundle ($599 billed)Compounded
$200/mo
tirzepatide
Brand 5/7.5/10/12.5/15 mgBrand-name
$1399/mo
mounjaro
Brand 2.5/5/7.5/10/12.5/15 mgBrand-name
$1399/mo
zepbound

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 400+ providers' prices on their own sites and email you when tracked prices move.

What’s included

Rebody Health

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Not disclosed

Vytora Health

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Rebody Health

7.6/10

Overall

Vytora Health

8.4/10

Value25%

7.5A
vs
B
8.0

Effectiveness25%

7.8A
vs
B
8.5

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.3A
vs
B
9.3

Accessibility10%

7.3A
vs
B
8.5

Support10%

7.3A
vs
B
8.4

Features & Coverage

FeatureRebody HealthVytora Health
Starting Price$199.99/mo$150/mo
Features8 features8 features
States Available4751
Compounded✓ Yes✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About Rebody Health

Rebody Health (rebodyhealth.com), operated by Compound Technologies Inc., is a transparent-pricing GLP-1 and wellness telehealth service that publishes prices up front. It offers compounded semaglutide and tirzepatide as weekly injections (from about $199.99 and $249.99/mo) and as daily oral 'melt' tablets, plus brand-name Wegovy and Zepbound, with dose-based pricing shown before each refill. Available in 47 states (not Massachusetts, Rhode Island, or Vermont). Rebody is not a pharmacy; prescriptions are prepared by licensed compounding pharmacies not named on the site.

Read our full Rebody Health review →

About Vytora Health

Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin peptides. It names its pharmacy partners publicly — Vials Pharmacy and Greenwich Biosciences — and discloses its operating physician group, uncommon transparency for the category. Compounded semaglutide runs $180/mo ($150 on a 3-month bundle) and tirzepatide $249/mo ($200 bundled).

Read our full Vytora Health review →

Pros & Cons

Rebody Health

What we like

  • Publishes transparent, dose-based pricing up front on a public pricing page, so you can see costs without signing up
  • Offers compounded semaglutide and tirzepatide as both weekly injections and daily oral 'melt' tablets
  • Also carries brand-name Wegovy and Zepbound for patients who want FDA-approved products
  • Clear plan-term vs dose-tier structure; the refill price is shown before each shipment, plus $50 off the first month
  • Names its operating company (Compound Technologies Inc.) and references LegitScript approval

Watch-outs

  • Individual compounding pharmacies are not named on the marketing site
  • Not available in Massachusetts, Rhode Island, or Vermont
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • Dose-scaled pricing means the monthly cost can rise as your prescribed dose increases

Vytora Health

What we like

  • All 50 states plus DC, with per-state video-vs-audio compliance disclosed
  • Both compounded and brand-name options on one platform — uncommon
  • LegitScript Approved and HIPAA compliant
  • Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
  • Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)
  • Competitive monthly pricing ($180 sema / $249 tirz) plus a 3-month bundle saving 17%
  • Brand-name Mounjaro and Zepbound available at $1,399/mo for FDA-approved options

Watch-outs

  • Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
  • Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
  • Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
  • Initial consultation cost not shown on the public pricing page
  • Limited per-prescriber state licensure detail

Our Verdict

Winner: Vytora Health

Vytora Health edges out Rebody Health with a higher overall score of 8.4/10 and is particularly strong for compounded or brand-name GLP-1 with named pharmacy partners, 50 states. Rebody Health remains a solid alternative, especially if you're looking for Shoppers who want transparent, dose-based GLP-1 pricing with oral, injectable, or brand-name options.

Choose Rebody Health if…

You want Shoppers who want transparent, dose-based GLP-1 pricing with oral, injectable, or brand-name options and a starting price around $199.99/mo.

Choose Vytora Health if…

You want compounded or brand-name GLP-1 with named pharmacy partners, 50 states and a starting price around $150/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.4

Telos Rx

Needle-free and microdosed compounded GLP-1 options with lab-monitored care

6.4

Direct Meds

Listed for transparent disclosure — see FDA warning and BBB complaint pattern before considering

7.6

Maximus

Men seeking compounded GLP-1 alongside testosterone optimization

Rebody Health vs Vytora Health: FAQ

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring Rebody Health and Vytora Health head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.